Julie Papanek Grant, Director at Day One Biopharmaceuticals, Inc. (DAWN), sold 8,716 shares at $22.08 ($192K) on 2022-12-08, disclosed to the SEC on 2022-12-12.
Open-market sale of $192k DAWN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.08 | 4,358 | $96K | 50.0% |
| 2 | $22.08 | 4,358 | $96K | 50.0% |
| Total | $22.08 avg | 8,716 | $192K | 100% |
| Filing → |
| DAWN | SELL | 2023-01-04 | $1.0M | — | Filing → |
| DAWN | SELL | 2022-12-05 | $320K | — | Filing → |
| DAWN | SELL | 2022-11-03 | $300K | — | Filing → |